A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
about
Advances and challenges in the management of complement-mediated thrombotic microangiopathiesTransplant-associated thrombotic microangiopathy: opening Pandora's box.Cardiovascular complications in atypical haemolytic uraemic syndrome.Antiphospholipid syndrome in renal transplantation.Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic SyndromeAn international consensus approach to the management of atypical hemolytic uremic syndrome in children.Modified Ham test for atypical hemolytic uremic syndromeDiabetic ketoacidosis presenting with atypical hemolytic uremic syndrome associated with a variant of complement factor B in an adult: a case report.Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.Acute Kidney Injury, Recurrent Seizures, and Thrombocytopenia in a Young Patient with Lupus Nephritis: A Diagnostic DilemmaLife-threatening pregnancy-associated atypical haemolytic uraemic syndrome and its response to eculizumab.Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab.Faster title and abstract screening? Evaluating Abstrackr, a semi-automated online screening program for systematic reviewers.Complement related kidney diseases: Recurrence after transplantation.An emerging molecular understanding and novel targeted treatment approaches in pediatric kidney diseases.Biologics for the treatment of autoimmune renal diseases.Immunotherapeutic strategies in antiphospholipid syndrome.Expediting citation screening using PICo-based title-only screening for identifying studies in scoping searches and rapid reviews.Evaluation of health-related quality of life in hemolytic uraemic syndrome patients treated with eculizumab: a systematic evaluation on basis of EMPRO.A case of atypical hemolytic uremic syndrome in a second renal transplant.Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults.Pregnancy-induced atypical haemolytic uremic syndrome: A new era with eculizumab.Hemolytic uremic syndrome
P2860
Q26796453-E9EF569E-CBC7-40C5-A55C-B25651FBFC32Q30235311-097B5DC3-9C51-4FFC-91E6-7CCEF88A00A0Q33412640-41261FFC-9626-48F2-BF91-90D5DA018D40Q33413394-53827EBE-1D4D-461B-9ACC-F7C7EC9A2D06Q33417375-97A07D9A-FFE2-4652-8776-7EB57F6F2EA1Q33421800-C6E5CB4F-F48D-4B8D-8A34-BF98F2881B3AQ33421861-6CD7931A-6FC9-48E7-B6CA-28936C5F41EEQ33421884-ACBFF055-8E91-4B5C-9303-D7CC6BE4904AQ33430267-80B8D40C-3D5B-403A-BD89-EBF1CAB01204Q33430681-ED77AE3C-AF7A-4185-A5B6-722A76B1E6D1Q33430817-DBC54B2C-AECC-41B2-8D76-E2DB8DE76772Q33438077-75EB0862-47E0-419D-98F0-019C6E8488B7Q33439118-F9D47A1F-9151-4A0F-A2CF-53E87363E279Q33441329-D93DDE9A-3645-4DCA-A689-FA5531284158Q35755300-7025C35A-1754-42B2-9892-F87CFA2EC7F0Q37522557-9964C89C-C511-4FDB-9CE1-F879ED00ABFEQ38232593-1781F3C4-528D-4D84-98AE-C54F4CAAA23FQ38763327-EC74ADCD-AA3B-42E8-B528-910C51B77D4DQ38826804-A1815D12-7A1F-462E-9432-36B5457C69EBQ47152021-0F4B11EE-92CD-4F6E-9D59-082A5D25535DQ48177829-22F75184-9A5C-476A-A605-E86A9096D80FQ48209875-538CFD87-E6DA-47D7-8BB8-77C4B1B0602AQ48255838-A838FDB8-6109-4C58-94CA-85B146F9D30AQ52595152-F71BD39C-D399-4AA6-9A7A-8CF90755E74EQ57701679-3F489C8D-96FF-4B85-A151-488B1E2DB2A8
P2860
A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
@ast
A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
@en
A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
@nl
type
label
A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
@ast
A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
@en
A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
@nl
prefLabel
A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
@ast
A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
@en
A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
@nl
P2093
P2860
P1433
P1476
A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
@en
P2093
Alice Bessey
Anna Richards
Eva Kaltenthaler
Paul Tappenden
P2860
P304
P356
10.1136/BMJOPEN-2013-003573
P407
P577
2013-11-04T00:00:00Z